Hidari KI - Search Results

1

Molecular design of spacer-N-linked sialoglycopolypeptide as polymeric inhibitors against influenza virus infection.

Ogata M, Hidari KI, Kozaki W, Murata T, Hiratake J, Park EY, Suzuki T, Usui T. Ogata M, et al. Among authors: hidari ki. Biomacromolecules. 2009 Jul 13;10(7):1894-903. doi: 10.1021/bm900300j. Epub 2009 May 13. Biomacromolecules. 2009. PMID: 19438195

2

Chemoenzymatic synthesis of sialoglycopolypeptides as glycomimetics to block infection by avian and human influenza viruses.

Ogata M, Hidari KI, Murata T, Shimada S, Kozaki W, Park EY, Suzuki T, Usui T. Ogata M, et al. Among authors: hidari ki. Bioconjug Chem. 2009 Mar 18;20(3):538-49. doi: 10.1021/bc800460p. Bioconjug Chem. 2009. PMID: 19215136

3

Chemoenzymatic synthesis of artificial glycopolypeptides containing multivalent sialyloligosaccharides with a gamma-polyglutamic acid backbone and their effect on inhibition of infection by influenza viruses.

Ogata M, Murata T, Murakami K, Suzuki T, Hidari KI, Suzuki Y, Usui T. Ogata M, et al. Among authors: hidari ki. Bioorg Med Chem. 2007 Feb 1;15(3):1383-93. doi: 10.1016/j.bmc.2006.11.006. Epub 2006 Nov 9. Bioorg Med Chem. 2007. PMID: 17129732

4

Chemoenzymatic synthesis, characterization, and application of glycopolymers carrying lactosamine repeats as entry inhibitors against influenza virus infection.

Hidari KI, Murata T, Yoshida K, Takahashi Y, Minamijima YH, Miwa Y, Adachi S, Ogata M, Usui T, Suzuki Y, Suzuki T. Hidari KI, et al. Glycobiology. 2008 Oct;18(10):779-88. doi: 10.1093/glycob/cwn067. Epub 2008 Jul 11. Glycobiology. 2008. PMID: 18621993

5

Dengue virus receptor.

Hidari KI, Suzuki T. Hidari KI, et al. Trop Med Health. 2011 Dec;39(4 Suppl):37-43. doi: 10.2149/tmh.2011-S03. Epub 2011 Aug 6. Trop Med Health. 2011. PMID: 22500135 Free PMC article.

6

Carbohydrate-related inhibitors of dengue virus entry.

Hidari KI, Abe T, Suzuki T. Hidari KI, et al. Viruses. 2013 Feb 6;5(2):605-18. doi: 10.3390/v5020605. Viruses. 2013. PMID: 23389466 Free PMC article. Review.

7

Influenza virus utilizes N-linked sialoglycans as receptors in A549 cells.

Hidari KI, Yamaguchi M, Ueno F, Abe T, Yoshida K, Suzuki T. Hidari KI, et al. Biochem Biophys Res Commun. 2013 Jul 5;436(3):394-9. doi: 10.1016/j.bbrc.2013.05.112. Epub 2013 Jun 4. Biochem Biophys Res Commun. 2013. PMID: 23747419

8

Chemoenzymatic synthesis and characterization of N-glycolylneuraminic acid-carrying sialoglycopolypeptides as effective inhibitors against equine influenza virus hemagglutination.

Ogata M, Koizumi A, Otsubo T, Ikeda K, Sakamoto M, Aita R, Kato T, Park EY, Yamanaka T, Hidari KIPJ. Ogata M, et al. Among authors: hidari kipj. Biosci Biotechnol Biochem. 2017 Aug;81(8):1520-1528. doi: 10.1080/09168451.2017.1325315. Epub 2017 May 18. Biosci Biotechnol Biochem. 2017. PMID: 28521605

9

Clarithromycin inhibits progeny virus production from human influenza virus-infected host cells.

Miyamoto D, Hasegawa S, Sriwilaijaroen N, Yingsakmongkon S, Hiramatsu H, Takahashi T, Hidari K, Guo CT, Sakano Y, Suzuki T, Suzuki Y. Miyamoto D, et al. Biol Pharm Bull. 2008 Feb;31(2):217-22. doi: 10.1248/bpb.31.217. Biol Pharm Bull. 2008. PMID: 18239276 Free article.

10

Purification and characterization of a soluble recombinant human ST6Gal I functionally expressed in Escherichia coli.

Hidari KI, Horie N, Murata T, Miyamoto D, Suzuki T, Usui T, Suzuki Y. Hidari KI, et al. Glycoconj J. 2005 Feb;22(1-2):1-11. doi: 10.1007/s10719-005-0845-9. Glycoconj J. 2005. PMID: 15864429

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

72 results

Search Page